Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
46,010,469
-
Share change
-
-3,622,034
-
Total reported value
-
$242,442,000
-
Put/Call ratio
-
63%
-
Price per share
-
$5.27
-
Number of holders
-
114
-
Value change
-
-$22,562,261
-
Number of buys
-
55
-
Number of sells
-
50
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q1 2016
As of 31 Mar 2016,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,010,469 shares.
The largest 10 holders included
VANGUARD GROUP INC, DEERFIELD MANAGEMENT CO, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, BB BIOTECH AG, FMR LLC, AMERIPRISE FINANCIAL INC, GOLDMAN SACHS GROUP INC, and PINNACLE ASSOCIATES LTD.
This page lists
114
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.